R&D + Strategic Partnering
for the Global Vaccine Industry

Holger Kissel Holger Kissel, Ph.D., serves as Senior Vice President Scientific Relations & Liaison at BioNTech. Being a part of the Company since 2013, he assumed this role in 2023. With an extensive background in business development and licensing, he is dedicated to advancing global health...

A passionate believer in science and the value vaccines bring to society, Charles has supported all phases of vaccine development and commercial activities for bacterial, viral, recombinant, and conjugated vaccines, as well as mRNA programs in development.  Charles leads a team of talented Reg CMC...

BRIAN DEAN ABRAMSON is a leading expert on vaccine law, and was the founding chair of the National Vaccine Law Conference. He teaches the subject as adjunct professor of vaccine law at the Florida International University College of Law, and at the University of Houston Law Center. He is the...

Dr. Navneet Bichha is a physician scientist from Nepal with a strong foundation in clinical medicine and public health, with a decade experience in vaccine research, policy implementation, and global health partnerships.  He currently serves as a Senior Program Officer at The INCLEN Trust...

Tom Mahoney is an experienced investor and philanthropist in the field of Immunology and Infectious Diseases, currently affiliated with the Harvard T.H. Chan School of Public Health Department of Immunology and Infectious Diseases. Tom's work is characterized by a deep commitment to public...

Victoria Standley is an experienced healthcare professional and public health advocate with over 18 years in service and leadership roles. She currently serves as an Immunization Program Specialist at Sanford Health, a large nonprofit health system serving 2.4 million patients across the Upper...

Professor Michael Good is a Principal Research Leader at the Institute for Biomedicine and Glycomics, Griffith University, Australia.  He heads the Laboratory of Vaccines for the Developing World.  He has developed candidate vaccines for the prevention of malaria and streptococcus and these have...

Raiees Andrabi is an Associate Professor of Medicine, Perelman School of Medicine, Division of Infectious Diseases, Department of Medicine, University of Pennsylvania. Raiees Andrabi earned his PhD degree from the All India Institute of Medical Sciences in Biochemistry and performed his...

Tonya Colpitts is an accomplished professional with a proven track record in the global vaccine industry. Currently serving as Associate Vice President and Global Project Head for Vaccines at Sanofi, Tonya brings a wealth of experience and expertise to vaccine development and infectious diseaes...

After 11 years as a veterinary practitioner, Alasdair King joined the pharmaceutical industry.  He has taken many roles including technical adviser, pharmacovigilance manager, and government liaison.  He has been responsible for the development of avian influenza vaccine banks and led the company...

Dr. Raymond P. Goodrich is a distinguished biomedical researcher and innovator with over 37 years of experience in transfusion medicine, pathogen reduction technologies, and immunotherapy. He is a tenured professor in the Department of Microbiology, Immunology, and Pathology at Colorado State...

  Nikki Romanik, MD, is the co-founder of BioRadar Public Benefit Company, an AI-powered biosurveillance and early-warning platform designed to detect emerging biological threats before they escalate into global crises. She also serves as an Advisor to Network 20/20, a global leadership network...

Jim brings over three decades of experience developing and commercializing vaccines intended to treat or prevent diseases that impact children and adults around the world. During this time, he held significant leadership positions in the vaccine divisions of Pfizer, Novartis and Merck. Prior to...

Dr. Robert T Chen has been active in research of vaccines and vaccine-preventable diseases for over 40 years, mostly at the US Centers for Disease Control and Prevention (CDC).  He played key roles in modernizing the vaccine safety infrastructure in the U.S. and elsewhere, including the creation of ...

As Global Head of Research and Development for Adjuvant Systems at Croda Pharma, Dennis Christensen is leading the effort to expand Croda’s offering of new and innovative vaccine delivery systems, immunostimulators and combined adjuvant systems. He has for more than 20 years been working with...

Trained as a biochemist at the Johns Hopkins University, the US National Institutes of Health and Duke University, Bill Hausdorff’s vaccine career started at the US Agency for International Development and Centers for Disease Control in Washington DC and Cairo, Egypt, where he worked to catalyze...

Vic is the Co-Founder and Principal Growth Partner of Blu Zone Bioscience & Supply Chain Solutions and a retired U.S. Army officer with over 27 years of service in biotechnology and healthcare logistics. He previously served as Chief of Staff at the Walter Reed Army Institute of...

Prashant Yadav is a senior fellow for global health at the Council on Foreign Relations (CFR). He is a globally recognized expert in healthcare supply chains and has published extensively on health product manufacturing, procurement, and distribution. Yadav’s writing has appeared in major print...